Mary Mosher

Array ( [id] => 8028261 [patent_doc_number] => 08143213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Effect of TULA on HIV' [patent_app_type] => utility [patent_app_number] => 12/439939 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20750 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143213.pdf [firstpage_image] =>[orig_patent_app_number] => 12439939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358654 [patent_doc_number] => 20120213813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'ALPHAVIRUS REPLICON PARTICLES AS IMMUNOLOGICAL ADJUVANTS' [patent_app_type] => utility [patent_app_number] => 11/854472 [patent_app_country] => US [patent_app_date] => 2007-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15404 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11854472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518504 [patent_doc_number] => 07972605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Modified vaccinia ankara virus vaccine' [patent_app_type] => utility [patent_app_number] => 12/310781 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 6211 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/972/07972605.pdf [firstpage_image] =>[orig_patent_app_number] => 12310781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4798199 [patent_doc_number] => 20080009785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Topical delivery of vaccines' [patent_app_type] => utility [patent_app_number] => 11/851956 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3592 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009785.pdf [firstpage_image] =>[orig_patent_app_number] => 11851956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765580 [patent_doc_number] => 20080176792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'VEGFR-1 TARGETING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/844952 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29752 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176792.pdf [firstpage_image] =>[orig_patent_app_number] => 11844952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7800668 [patent_doc_number] => 08128938 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-03-06 [patent_title] => 'Influenza virus vaccine composition and methods of use' [patent_app_type] => utility [patent_app_number] => 11/892016 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 59807 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/128/08128938.pdf [firstpage_image] =>[orig_patent_app_number] => 11892016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441907 [patent_doc_number] => 20100104598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS' [patent_app_type] => utility [patent_app_number] => 12/376756 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 11403 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104598.pdf [firstpage_image] =>[orig_patent_app_number] => 12376756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13099 [patent_doc_number] => 07807345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Kits for detection of segmented negative strand RNA viruses' [patent_app_type] => utility [patent_app_number] => 11/832875 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9035 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807345.pdf [firstpage_image] =>[orig_patent_app_number] => 11832875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4802672 [patent_doc_number] => 20080014260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY' [patent_app_type] => utility [patent_app_number] => 11/778788 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5446 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014260.pdf [firstpage_image] =>[orig_patent_app_number] => 11778788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657147 [patent_doc_number] => 20080026008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Bacteriophage DNA vaccine vector' [patent_app_type] => utility [patent_app_number] => 11/879216 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2675 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026008.pdf [firstpage_image] =>[orig_patent_app_number] => 11879216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540206 [patent_doc_number] => 08058049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Process for producing poxviruses and poxvirus compositions' [patent_app_type] => utility [patent_app_number] => 12/304353 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8238 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058049.pdf [firstpage_image] =>[orig_patent_app_number] => 12304353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9085828 [patent_doc_number] => 08557251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Non-live trivalent influenza vaccine for one-dose intradermal delivery' [patent_app_type] => utility [patent_app_number] => 11/762488 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9032 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11762488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812849 [patent_doc_number] => 20080193480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Infectious Bursal Disease Virus antigenic isolates and vaccines' [patent_app_type] => utility [patent_app_number] => 11/811222 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6838 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193480.pdf [firstpage_image] =>[orig_patent_app_number] => 11811222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310163 [patent_doc_number] => 20090017444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Screening method for modulators of viral transcription or replication' [patent_app_type] => utility [patent_app_number] => 11/810956 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12228 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017444.pdf [firstpage_image] =>[orig_patent_app_number] => 11810956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581905 [patent_doc_number] => 20100291115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR THE SUBLINGUAL ADMINISTRATION OF VACCINES, METHOD FOR THE PREPARATION OF THE SAME AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/303726 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2353 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291115.pdf [firstpage_image] =>[orig_patent_app_number] => 12303726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43179 [patent_doc_number] => 07776521 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-08-17 [patent_title] => 'Coronavirus isolated from humans' [patent_app_type] => utility [patent_app_number] => 11/748359 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 22406 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776521.pdf [firstpage_image] =>[orig_patent_app_number] => 11748359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618771 [patent_doc_number] => 07998485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Sialoadhesin-related compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/227106 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 18 [patent_no_of_words] => 43151 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998485.pdf [firstpage_image] =>[orig_patent_app_number] => 12227106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91676 [patent_doc_number] => 07732132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Monoclonal antibody to the common epitope of NSs protein of watermelon silver mottle virus and assay for tospovirus' [patent_app_type] => utility [patent_app_number] => 11/789192 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4683 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732132.pdf [firstpage_image] =>[orig_patent_app_number] => 11789192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563680 [patent_doc_number] => 20090136532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Vaccine for Avian Influenza and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/296729 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10994 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136532.pdf [firstpage_image] =>[orig_patent_app_number] => 12296729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 52234 [patent_doc_number] => 07771725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Medicinal concentrate of arbovirus specific immunoglobulins and F(ab)\'2 and/or Fab fragments' [patent_app_type] => utility [patent_app_number] => 11/912444 [patent_app_country] => US [patent_app_date] => 2007-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4327 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/771/07771725.pdf [firstpage_image] =>[orig_patent_app_number] => 11912444 [rel_patent_id] =>[rel_patent_doc_number] =>)